Patients Whose First Episode of Bleeding Occurs While Taking a β-Blocker Have High Long-term Risks of Rebleeding and Death Andrea Ribeiro de Souza, Vincenzo La Mura, Enric Reverter, Susana Seijo, Annalisa Berzigotti, Eyal Askenazhi, Juan Carlos García– Pagán, Juan G. Abraldes, Jaime Bosch Clinical Gastroenterology and Hepatology Volume 10, Issue 6, Pages 670-676 (June 2012) DOI: 10.1016/j.cgh.2012.02.011 Copyright © 2012 AGA Institute Terms and Conditions
Figure 1 Enrollment of patients included in the study. Clinical Gastroenterology and Hepatology 2012 10, 670-676DOI: (10.1016/j.cgh.2012.02.011) Copyright © 2012 AGA Institute Terms and Conditions
Figure 2 (A) Cumulative incidence of rebleeding at 2 years. (B) Cumulative incidence of variceal rebleeding at 2 years. (C) Actuarial probability of OLT-free survival at 2 years. Clinical Gastroenterology and Hepatology 2012 10, 670-676DOI: (10.1016/j.cgh.2012.02.011) Copyright © 2012 AGA Institute Terms and Conditions